Remote Monitoring Supports Early Hearth Failure Detection: Study

Personal healthcare product manufacturer OMRON Healthcare has concluded a three-month study demonstrating that remote monitoring of vital signs can support early clinical intervention in patients with heart failure.

Conducted in partnership with the Kyoto Prefectural University of Medicine and supported by Japan’s Ministry of Economy, Trade, and Industry (METI), the study evaluated how real-time sharing of home-monitored health data can help detect early signs of heart failure. Cost-effective wearables have the potential to advance health equity on a large scale by providing a direct link between patients and a broader network of support through virtual connectivity.

Patients recorded daily health metrics using OMRON smart devices and the OMRON connect app, which automatically transmitted the data to certified cardiovascular nurses and heart failure specialists. When early indicators of deterioration were identified, patients were contacted directly and referred for clinical assessment.

Early detection is a critical component in managing heart failure. Detecting heart failure early is essential to ensure patients receive the best recommended treatments, helping to lower illness severity and death rates. The study reports that about 33% of participants exhibited warning signs that enabled timely intervention and treatment, potentially reducing both health risks and healthcare costs.

In addition to health outcomes, the study observed strong patient engagement. Over 90% of participants continued daily health measurements throughout the study, and 86% expressed high satisfaction with integrating home-monitored data into their personal health routines.

The study aligns with OMRON Healthcare’s broader vision, Going for ZERO, which aims to eliminate cardiovascular events through home ECG and blood pressure monitoring. The company plans to continue developing user-friendly devices and to collaborate with healthcare providers and researchers in advancing preventive cardiac care.

Heart failure affects over 60 million people globally and is the leading cause of hospitalization among individuals over 65, reports Bayer. In Mexico, about 15 million people fall within this age group. The country faces a high prevalence of risk factors such as hypertension, diabetes, and obesity, further increasing vulnerability.